Investor presentation is up.
https://dcxindia.com/wp-content/uploads/2024/02/Investors-Presentation-Q3-FY-2023-24.pdf
Investor presentation is up.
https://dcxindia.com/wp-content/uploads/2024/02/Investors-Presentation-Q3-FY-2023-24.pdf
Company issued ~1500 crores of ESOPs in last 1.5 months, they will have a drag of around 700 crores in next 4 quarters… I still feel 1500 to 1800 crores of PAT can be done by end of FY2025…
I have asked the management for no of patients in anti drone sys as i was having conversations with them earlier via mail lets wait for there reply
Dis-Invested
Q3 FY 2023-34 QUARTERLY RESULTS
Financials
The patent/patent application – Retofit tracking system is not related to Anti-drone system. A drawing from Indian Patent reveals this.
Also I have analysed to the best of my ability all the 89 patents or patent application mentioned in the reply of @vikas_sinha No one is related to Anti-drone system.
Even after spending lot of time on Indian Patents online search and WIPO I could not find remaining 41 patent or patent applications.
This looks like a dead end. We have two options now –
To ask the management of company to respond to assertion that company doesn’t have many patent or patent application related to anti-drone systems.
To hire a Patent attorney to find remaining 41 patent or patent application and then we can analyse them.
Thanks
Gaurav Agarwal
All the information provided in this post are from open sources and I may be completely wrong.
As per my estimate revenue should cross 6100 crores and profit 500 crores
Let’s not jump. Call is tomorrow 11:30am. Let’s wait.
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!